ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $29,560,000 | -14.4% | 4,000,000 | -26.0% | 1.43% | -29.4% |
| Q1 2016 | $34,539,000 | +2.2% | 5,405,235 | 0.0% | 2.02% | -7.3% |
| Q4 2015 | $33,783,000 | +4.5% | 5,405,235 | -2.3% | 2.18% | -21.1% |
| Q3 2015 | $32,313,000 | -32.0% | 5,533,118 | -3.8% | 2.77% | -14.5% |
| Q2 2015 | $47,553,000 | -17.6% | 5,750,000 | -17.9% | 3.24% | -21.4% |
| Q1 2015 | $57,680,000 | +11.9% | 7,000,000 | -6.7% | 4.12% | +20.2% |
| Q4 2014 | $51,525,000 | +59.0% | 7,500,000 | +25.0% | 3.43% | +12.5% |
| Q3 2014 | $32,400,000 | +1.7% | 6,000,000 | +20.0% | 3.04% | +45.9% |
| Q2 2014 | $31,850,000 | +31.7% | 5,000,000 | +66.7% | 2.09% | +10.1% |
| Q1 2014 | $24,180,000 | -32.5% | 3,000,000 | -42.9% | 1.90% | -40.0% |
| Q4 2013 | $35,805,000 | – | 5,250,000 | – | 3.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |